|
|
 |
| |
|
Home > Drug Companies > Genzyme Corporation
Genzyme Corporation
One of the world's foremost biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Founded in Boston in 1981, Genzyme has grown from a small start up to a diversified enterprise with annual revenues exceeding $2 billion and more than 8,000 employees in locations spanning the globe.
With many established products and services helping patients in more than 80 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences to address a range of unmet medical needs. The company's products and services are focused on rare inherited disorders, kidney disease, orthopaedics, transplant and immune disease, cancer, and diagnostic testing. Genzyme's commitment to innovation continues today with a substantial research and development program focused on genetic diseases, immune system disorders, heart disease, and cancer.
Genzyme focuses its efforts in medical and technology areas where it can make a major positive impact on the lives of patients with serious diseases and medical conditions Approximately 200 patients are receiving humanitarian enzyme therapy in countries around the globe, including Belarus, China, Cuba, Ecuador, Egypt, Haiti, India, Jamaica, Kenya, Pakistan, Sri Lanka, Tanzania, Ukraine, Vietnam, and Yugoslavia.
The Company hopes to expand this program and to create new programs for their other life saving products and services. Genzyme has a program dedicated to helping gaucher patients and their families. An important component of this program is their commitment to make Cerezyme, an enzyme replacement therapy and Genzyme's lead product, available to gaucher patients who need them.
Back to Drug Companies
|
|
|
|
|
|
|
|